Highbridge Capital Management’s Aegerion Pharmaceuticals AEGR Stock Holding History

Highbridge Capital Management’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-81,135	Closed	-$186K	–	2010
2016 Q1	$300K	Buy	81,135 +60,443	+292%	+$374K	0.01%	1183
2015 Q4	$209K	Buy	+20,692	New	+$249K	﹤0.01%	1335
2013 Q4	–	Sell	-93,303	Closed	-$8M	–	1496
2013 Q3	$8M	Sell	93,303 -8,385	-8%	-$711K	0.08%	261
2013 Q2	$6.44M	Buy	+101,688	New	+$5.4M	0.06%	282

Highbridge Capital Management's AEGR Position: Q2 2016 in Review

Highbridge Capital Management sold out of Aegerion Pharmaceuticals (AEGR) in Q2 2016, closing a stake of 81,135 shares — an estimated $186K sold.

Highbridge Capital Management first reported a position in AEGR in Q2 2013 and held it in 4 quarters. The position peaked at $8M in Q3 2013. 71 funds tracked by Wall St. Rank hold AEGR as of Q2 2016.

Highbridge Capital Management reported no remaining Aegerion Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
Highbridge Capital Management sold 81,135 Aegerion Pharmaceuticals shares in Q2 2016, an estimated $186K.
Highbridge Capital Management first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 4 quarters.
Highbridge Capital Management's Aegerion Pharmaceuticals position peaked at $8M in Q3 2013.
71 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2016.

Based on Highbridge Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.